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INTRODUCTION
The incidence of multifetal pregnancies has increased over the past years due to the introduction of assisted reproductive technology (ART) and the widespread use of ovulation-induction agents 1 . Despite a decrease in the number of embryos transferred in women undergoing ART in recent years 2 , resulting in a lower incidence of multifetal pregnancies in such cases, ovulation induction and intrauterine insemination with ovarian hyperstimulation also carry a risk of multifetal pregnancy 3 . Multifetal pregnancy is associated with a significant increase in perinatal morbidity and mortality, which appears to be related directly to the number of fetuses. The mean estimated gestational age at birth is 35 weeks for twins, 33 weeks for triplets and 29 weeks for quadruplets 1, 4, 5 , and the risk of very preterm birth increases by almost five-fold for twins and by 20-fold for triplets 2 . To reduce the incidence of fetal loss, preterm delivery and perinatal morbidity in multifetal pregnancies, multifetal pregnancy reduction (MPR) is offered to some patients. Several studies have shown that MPR to twin or singleton pregnancy improves obstetric outcomes compared with expectant management 3, 4, 6, 7 . Two MPR methods that are performed under ultrasonographic guidance are practiced, namely transvaginal ultrasound-guided embryo reduction (ER), which is performed at between 7 and 8 weeks of gestation 8, 9 , and transabdominal ultrasound-guided fetal reduction (FR), which is performed after 11 weeks of gestation. While some studies have investigated the fetal loss rate associated with each procedure independently, few have compared the two techniques.
The primary aim of the present study was to compare the obstetric outcome of multifetal pregnancies undergoing reduction to twin or singleton pregnancy by transvaginal ER vs transabdominal FR performed after a detailed anomaly scan. The secondary aim was to compare the incidence of procedure-related adverse events between the two groups.
METHODS
Between December 2006 and January 2017, 510 MPRs were performed at the Fertility Center and at the Department of Obstetrics and Gynecology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea. Exclusion criteria were premature rupture of membranes before MPR, undergoing MPR for the second time in the present pregnancy, or remaining fetus having known chromosomal anomaly or lethal anatomical defect. After exclusions, 296 patients were included in the study. ER was performed on 181 patients with gestational age between 6 and 8 weeks, by two operators at the Fertility Center. FR was performed after sonographic fetal anomaly scan and, if needed, chorionic villus sampling (CVS) on 115 patients with gestational age between 11 and 20 weeks, by one operator at the Department of Obstetrics and Gynecology.
A transvaginal approach was used for ER. The patient was placed in the lithotomy position and the vagina was painted with povidone-iodine. Under ultrasound guidance, a 17-gauge needle was inserted through the internal cervical os and directed towards the gestational sac. Hand suction was used to aspirate the fluid and fetus from the sac. If required, the catheter was then directed towards another sac. The criteria for the selection of the target fetus(es) were as follows: monochorionic twins, fetus with a weak heartbeat, fetus with shorter than expected crown-rump length or smaller than expected gestational sac; if all of the above criteria were normal, the easiest fetus to approach was selected.
FR was performed transabdominally. The patient's abdomen was painted with povidone-iodine and draped. Under the guidance of an abdominal ultrasound transducer, a 22-gauge needle was inserted into the uterine cavity and into the fetal heart or thoracic cavity, an intracardiac or intrathoracic injection of potassium chloride was administered and the fetal heart was monitored visually for asystole. The needle was removed after confirming the arrest of the fetal heart. CVS was performed before the FR, if indicated or desired by the patient. The criteria for the selection of the target fetus(es) were as follows: fetus with anatomical defect, including an enlarged nuchal translucency, or chromosomal anomaly; if the above criteria were normal, the easiest fetus to approach was selected.
All procedures were completed within 5 min of the punctures. Data were collected retrospectively at the Fertility Center and the Department of Obstetrics and Gynecology following institutional review board approval (2017-04-037-001). Maternal characteristics studied included demographic data, conception mode, gestational age at the time of fetal reduction and chorionicity. Conception mode was defined as spontaneous or achieved through ART, which included controlled ovarian hyperstimulation, intrauterine insemination and in-vitro fertilization via intracytoplasmic sperm injection. The indications for MPR were triplets, higher-order pregnancy, severe fetal anatomical abnormality determined by ultrasonography, chromosomal abnormality, poor obstetric history and miscellaneous indications, which included severe adenomyosis, large uterine scar and other factors that contributed to inability to bear multiple fetuses. Chorionicity was determined at the first-trimester ultrasound scan or post-delivery by histological analysis of the placenta.
Obstetric outcomes assessed in this study included miscarriage rate (defined as delivery < 24 weeks' gestation), early (24 + 0 to 33 + 6 weeks) and late (34 + 0 to 36 + 6 weeks) preterm delivery, term (≥ 37 weeks) delivery, maternal complications and fetal loss (defined as the loss of one or two fetuses during pregnancy). Procedure-related adverse outcomes assessed included the visualization of a subchorionic hematoma (SCH) by ultrasound (defined as a retroplacental, hypoechoic region evaluated by an obstetric sonologist) and procedure-related fetal loss (defined as the loss of one or two fetuses within 4 weeks of the procedure).
Statistical analysis was performed using SPSS Statistics software, version 23 (IBM Corp., Armonk, NY, USA). The statistical significance of the differences between the ER and FR groups was analyzed using the χ 2 test, Fisher's exact test, the Mann-Whitney U-test, and two-tailed unpaired Student's t-test, as appropriate. Logistic regression analysis was used for the multivariate analysis while controlling for the effects of the potential confounders, which included the initial and final embryo numbers, maternal age, body mass index, parity, mode of conception and procedural indications. A P-value < 0.05 was considered statistically significant.
RESULTS
The study comprised 181 patients who underwent ER and 115 patients who underwent FR. Table 1 presents the characteristics of the subjects. Maternal age and weight did not differ significantly between the two groups. Significant differences were noted in relation to parity and mode of conception, with more women being parous in the FR (27.0%) compared with the ER (14.9%) group and a higher rate of spontaneous conception in the FR (3.5%) compared with that in the ER (0%) group. The mean gestational age at which the procedure was performed was 7.6 ± 0.5 weeks for ER and 12.9 ± 1.9 weeks for FR (P < 0.001). Significant differences were noted between the ER and FR groups with respect to the mean initial 7.6 ± 0.5 12.9 ± 1.9 < 0.001
Number of embryos Before procedure 3.2 ± 0.6 2.7 ± 0.6 < 0.001 After procedure 1.9 ± 0.3 1.5 ± 0.5 < 0.001
Data are presented as mean ± SD or n (%). BMI, body mass index; COH, controlled ovarian hyperstimulation; GA, gestational age; IUI, intrauterine insemination; IVF/ICSI, in-vitro fertilization by intracytoplasmic sperm injection. Data are presented as n (%).
number (3.2 vs 2.7) and mean final number (1.9 vs 1.5) of embryos (P < 0.001 for both). Triplets and higher-order pregnancy were more commonly the indication for fetal reduction in the ER group, whereas anatomical abnormalities on ultrasound, chromosomal anomaly, poor obstetric history and miscellaneous indications were more common in the FR group ( Table 2) . Most of the pregnancies (n = 216) were reduced to twins. Triplets and twins with monochorionic pairings, and triplets and twins of mothers with severe adenomyosis, poor obstetric history and other factors associated with inability to bear multiple fetuses were reduced to singleton pregnancies. Twenty-nine (9.8%) multifetal pregnancies with monochorionic pairings were reduced to singleton or twin pregnancies.
No immediate procedure-related complications occurred. Procedure-related adverse events tended to be more frequent after ER than after FR. The incidences of SCH and procedure-related fetal loss were higher in the ER compared with the FR group (P < 0.05) ( Table 3) .
After adjusting for the potential confounders described previously, the frequency of SCH detected in the 4 weeks following the procedure remained higher in the ER group compared with that in the FR group (40.2% vs 6.4%; adjusted P < 0.001) (odds ratio (OR), 0.1; 95% CI, 0.05-0.23). The incidence of procedure-related fetal loss also remained higher in the ER compared with that in the FR group (7.2% vs 0.9%; adjusted P = 0.039) (OR, 0.12; 95% CI, 0.02-0.89).
Obstetric outcomes are presented in Table 4 . The overall fetal loss rate was higher after ER compared with after FR (13.3% vs 5.2%; adjusted P = 0.031) (OR, 0.36; 95% CI, 0.14-0.91). Miscarriage rate was significantly higher in the ER compared with the FR group (8.8% vs 2.6%; adjusted P = 0.045) (OR, 0.28; 95% CI, 0.08-0.97). More women in the ER group had early preterm delivery at 24-34 gestational weeks, whereas more women in the FR group had term delivery, but these findings were not statistically significant after adjusting for the potential confounders. The groups did not differ with respect to maternal complications. Regarding twin births, the mean gestational age at delivery was significantly lower in twins born after ER than in those born after FR (34.2 vs 35.7 weeks; P = 0.014). There was no difference between the two groups with respect to mean gestational age at delivery of the singleton pregnancies or mean birth weight of the twin and singleton babies.
DISCUSSION
Multifetal pregnancy has been linked to preterm delivery, which is associated with neonatal mortality and morbidity. The number of multifetal pregnancies continues to increase due to increase in maternal age and ART 10, 11 . Many investigations into MPR-associated fetal loss have focused on the individual procedures or MPR timing. Findings from studies that compared MPR according to the procedure used indicated that the 2-week post-procedural fetal loss rates following transvaginal or transabdominal MPR were between 1.5 and 4.5% 12 16 .
Unlike previous studies that investigated the rate of fetal loss associated with individual procedures or MPR timing, in this study we compared the procedure-related and obstetric outcomes of early ER vs late FR. In a study investigating the obstetric outcome of twins, Haas et al. reported higher losses of one fetus after early transvaginal MPR at 6-8 weeks' gestation compared with after late transabdominal MPR at 11-14 weeks' gestation (6% vs 0.8%; P = 0.04) 8 . Similarly, in the present study, the overall fetal loss rate associated with ER was higher than that associated with FR, but the rate (13.3%) Data are presented as n (%) or n/N (%). *Adjusted for number of embryos before and after reduction, maternal age, body mass index, parity, mode of conception and procedural indications. †Defined as loss of one or two fetuses within 4 weeks of procedure. ‡Data missing in some cases. NS, not significant. Data are represented as n (%) or mean ± SD, unless otherwise indicated. *Adjusted for number of embryos before and after reduction, maternal age, body mass index, parity, mode of conception and procedural indications. †Defined as loss of one or two fetuses during pregnancy. ‡Defined as delivery < 24 weeks' gestation. GA, gestational age; IIOC, incompetence of internal os of cervix; NS, not significant; PPROM, preterm prelabor rupture of membranes.
was higher than that reported by Haas et al. (5.2%) 8 (P = 0.031) (OR, 0.36; 95% CI, 0.14-0.91). Our study was conducted at a tertiary university hospital with more high-risk patients, which may explain this discrepancy. We additionally investigated the incidence of pre-and postprocedural SCH. The prevalence of first-trimester vaginal bleeding tends to increase with SCH depending on its size and location. First-trimester bleeding correlates with higher preterm birth and fetal loss rates, and lower birth weight [17] [18] [19] [20] . Pregnancy outcomes and fetal mortality and morbidity correlate directly with the duration and amount of first-trimester bleeding in triplet pregnancies after MPR 21 . In this study, the SCH frequency was higher following ER than after FR, which might have caused more adverse obstetric outcomes. The high ER-associated SCH rate may be linked to embryo aspiration creating an empty space that can fill with blood, which does not occur after FR.
The mean gestational ages at delivery for twin and singleton pregnancies after MPR have been reported as 38 weeks and 35.2 weeks, respectively, which concurs with our results 22 . The mean gestational age at delivery of the twins in this study was 1.5 weeks earlier in pregnancies that underwent ER compared with those that had FR, a difference that was significant. This finding is not in accordance with the study of Haas et al. 8 in which no differences were evident between the groups regarding the preterm and term delivery rates 8 . The use of a 17-gauge needle, the high SCH rate or the transvaginal approach in the ER group may explain the higher ER-associated fetal loss rate. If all fetuses were normal in a pregnancy, the fetus closest to the cervix was selected for removal in ER, which may increase the rates of preterm delivery and adverse obstetric outcome; in contrast, in FR, the fetus at the fundus was targeted.
Early ER is more acceptable from religious and ethical perspectives, and toxic substances are not necessary 6, 9 .
However, ER may be performed prematurely, causing the spontaneous demise of the remaining fetus(es) 9, 23 . The vanishing twin rates are 38% in pregnancies achieved following ART and 7.3% following spontaneous conception, and almost 90% occur during the first 7 weeks of pregnancy 24 . Berkowitz et al. recommend including information about the naturally occurring vanishing twin phenomenon when counseling patients for MPR, particularly in relation to the procedure's timing 25 . Another disadvantage of ER is that congenital malformations or chromosomal abnormalities may be found later in the remaining fetus(es). Fetal anomalies are rarely visible by ultrasonography at 6-8 weeks' gestation, particularly when four or five gestational sacs are present in the uterine cavity and the fetuses overlap on the scanning planes. Only small crown-rump lengths or irregularly shaped gestational sacs influence decisions about which fetus(es) to remove 26 . Two cases were diagnosed with pentalogy of Cantrell at 11-15 weeks after ER and underwent FR; these cases were excluded from the study population.
Comprehensive anomaly scans, CVS and non-invasive prenatal testing can be performed before FR, which underlines the advantages of FR 27 . In this study, 21 cases underwent CVS and five cases had true chromosomal abnormalities, while ultrasound-detected anomalies were found in six cases. The median gestational age at which FR was performed was 12.9 weeks in this study. Delaying FR to beyond 12-14 weeks' gestation has no advantages, because detailed fetal anomaly scans can be performed by that time, and the psychological difficulty associated with decision-making can become greater as the pregnancy progresses 25, 28 . In this study, 10 (8.7%) cases underwent FR after 14 weeks' gestation because chromosomal abnormalities and/or anatomical defects were detected by amniocentesis and level-II ultrasound scanning.
Limitations of our study include its retrospective nature. FR was performed by one of the authors, whereas ER was performed by two of the authors. Unlike other studies, the gestational age range for FR was broad (11-20 weeks); however, we excluded cases with complications that could affect the fetal loss rate. The study's tertiary university hospital setting may have led to more adverse outcomes. Strengths of the study are associated with it being a single-center study with a relatively large sample size, and the adequate follow-up between the procedure and delivery. Furthermore, and unlike previous studies, we investigated the incidence of procedure-related adverse events.
In conclusion, this is one of the few studies to compare ER with FR in MPR. FR was associated with fewer procedure-related adverse events and a lower overall fetal loss rate. Additionally, ultrasound and non-invasive or invasive prenatal testing can be performed before FR to detect genetically and anatomically abnormal fetuses. Despite the psychological and religious benefits associated with ER, the FR procedure is overall a better and safer approach to the reduction of morbidity and mortality rates in multifetal pregnancies.
